rs74586298

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000709.4(BCKDHA):​c.996-6G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0054 in 1,608,210 control chromosomes in the GnomAD database, including 382 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 185 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 197 hom. )

Consequence

BCKDHA
NM_000709.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00002503
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.808

Publications

3 publications found
Variant links:
Genes affected
BCKDHA (HGNC:986): (branched chain keto acid dehydrogenase E1 subunit alpha) The branched-chain alpha-keto acid (BCAA) dehydrogenase (BCKD) complex is an innter mitochondrial enzyme complex that catalyzes the second major step in the catabolism of the branched-chain amino acids leucine, isoleucine, and valine. The BCKD complex consists of three catalytic components: a heterotetrameric (alpha2-beta2) branched-chain alpha-keto acid decarboxylase (E1), a dihydrolipoyl transacylase (E2), and a dihydrolipoamide dehydrogenase (E3). This gene encodes the alpha subunit of the decarboxylase (E1) component. Mutations in this gene result in maple syrup urine disease, type IA. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
BCKDHA Gene-Disease associations (from GenCC):
  • maple syrup urine disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • maple syrup urine disease type 1A
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P, ClinGen, Myriad Women’s Health
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-41422992-G-A is Benign according to our data. Variant chr19-41422992-G-A is described in ClinVar as Benign. ClinVar VariationId is 93390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0938 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000709.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHA
NM_000709.4
MANE Select
c.996-6G>A
splice_region intron
N/ANP_000700.1P12694-1
BCKDHA
NM_001164783.2
c.993-6G>A
splice_region intron
N/ANP_001158255.1Q59EI3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCKDHA
ENST00000269980.7
TSL:1 MANE Select
c.996-6G>A
splice_region intron
N/AENSP00000269980.2P12694-1
ENSG00000255730
ENST00000540732.3
TSL:2
c.1098-6G>A
splice_region intron
N/AENSP00000443246.1F5H5P2
BCKDHA
ENST00000906426.1
c.1065G>Ap.Leu355Leu
synonymous
Exon 8 of 9ENSP00000576485.1

Frequencies

GnomAD3 genomes
AF:
0.0278
AC:
4222
AN:
152022
Hom.:
183
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0960
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.00723
AC:
1722
AN:
238176
AF XY:
0.00548
show subpopulations
Gnomad AFR exome
AF:
0.0969
Gnomad AMR exome
AF:
0.00568
Gnomad ASJ exome
AF:
0.00153
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000401
Gnomad OTH exome
AF:
0.00344
GnomAD4 exome
AF:
0.00305
AC:
4438
AN:
1456070
Hom.:
197
Cov.:
35
AF XY:
0.00261
AC XY:
1889
AN XY:
723742
show subpopulations
African (AFR)
AF:
0.0999
AC:
3328
AN:
33326
American (AMR)
AF:
0.00587
AC:
258
AN:
43942
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
45
AN:
25984
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39458
South Asian (SAS)
AF:
0.000282
AC:
24
AN:
85086
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52894
Middle Eastern (MID)
AF:
0.00469
AC:
27
AN:
5762
European-Non Finnish (NFE)
AF:
0.000279
AC:
310
AN:
1109510
Other (OTH)
AF:
0.00742
AC:
446
AN:
60108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
255
510
766
1021
1276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0279
AC:
4246
AN:
152140
Hom.:
185
Cov.:
33
AF XY:
0.0264
AC XY:
1965
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.0963
AC:
3992
AN:
41450
American (AMR)
AF:
0.0107
AC:
163
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000456
AC:
31
AN:
68022
Other (OTH)
AF:
0.0217
AC:
46
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
183
366
550
733
916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
38
Bravo
AF:
0.0320
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Maple syrup urine disease (2)
-
-
2
not specified (2)
-
-
1
Maple syrup urine disease type 1A (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.49
DANN
Benign
0.70
PhyloP100
-0.81
PromoterAI
0.0049
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000025
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74586298; hg19: chr19-41928897; API